Advanced Medical Isotope (AMIC), a developer of medical isotopes, has filed 510(k) pre-market notification to the US Food and Drug Administration (FDA) approval for its Yttrium-90 RadioGel brachytherapy cancer product. In accordance to ...
We all are extremely conscious towards the health realted concerns, hence it is important to eat balanced and protein-rich diet in our daily routine. Today, soyabean is considered as a healthy source of proteins, vitamins and saturated ...
Tags: Soyabean, Processing Machinery
Gord McNeil, prostate-cancer survivor and the past president of the Toronto Transportation Club (TTC), has officially issued a MOvember challenge to his other truckers in the area. "We need to get the word out to all males over 40 to get ...
Tags: Transportation, bike, Auto Parts
Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
The University of Michigan’s Department of Pathology MLabs has announced the commercial availability of Mi-prostate score (MiPS) test for men, a new urine test that measures minute fragments of RNA in prostate cancer. The test ...
Tags: Prostate Cancer, Medicine
NeoTract has received an approval from the US Food and Drug Administration (FDA) to market its UroLift system, designed to relieve low or blocked urine flow in men age 50 and older with an enlarged prostate (benign prostatic hyperplasia). ...
Tags: Prostate Implant, Neotract
Molecular diagnostic company Myriad Genetics has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test for hereditary cancer testing. The new test analyses 25 genes that are associated with breast, colorectal, ovarian, ...
Tags: Multi-Gene Test, Medicine
LifeAgain Insurance Solutions, a wholly-owned subsidiary of Cardium Therapeutics, has signed a commercialisation agreement with insurance broker AgencyONE to support the development and marketing of new survivable risk life insurance ...
Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers. The Janssen Research & Development will manage compound ...
Berg has signed a cooperative research and development agreement with the US Department of Defense, to advance prostate cancer research. The Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research ...
Tags: Berg, Prostate Cancer Research
Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
Elekta, a Sweden-based medical technology company, has received CE Mark for its Clarity 4D Monitoring system. 4D monitoring offers continuous tracking of the prostate and imaging of the surrounding anatomy, including the bladder, rectum ...
Astellas Pharma has announced the availability of Xtandi (enzalutamide), a new treatment for advanced prostate cancer in patients who have failed on first-line hormonal treatments and docetaxel chemotherapy, in the UK. Administered ...
Tags: Astellas, Cancer Medication
US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...
Tags: Johnson&Johnson, Medicine
The US Patent and Trademark Office (USPTO) has granted a patent to GenSpera for the activation of peptide prodrugs by HK2, which is an enzyme secreted by prostate cancer cells. Composition of a series of prodrugs activated by HK2 enzyme ...
Tags: Peptide Prodrugs, Medicine